A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...

Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized ...

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can ...

Nimbus Therapeutics, LLC ("Nimbus Therapeutics" or "Nimbus"), a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery ...

Background Heart failure (HF) guidelines recommend routine testing for iron deficiency (ID) and, for those with ID, ...

Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...

An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...

A multidisciplinary team of University of Miami researchers studying factors associated with health outcomes and disease risk in the Hispanic community has received a $21 million grant from the ...

Because of the risks biopsies can pose to patients, the FDA recommends only requiring them as part of trial participation if ...

In the world of drug development, the timing and design of clinical trials can be crucial in getting a new drug to market ...

The research spans the entire biomedical field – from basic experimental research to clinical studies in collaboration with the health care system. Pioneering research is conducted here in, for ...